Fase II studies bij diverse tumoren

Op deze pagina

Planned

There are currently no planned studies in our center.

Ongoing

Closed

I3Y-MC-JPBO

A phase II study of abemaciclib in patients with brain metastases secondary to hormone receptor positive breast cancer and melanoma

CHECKMATE 848 CA209-848

A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination With Ipilimumab or Nivolumab Monotherapy in Participants With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

CREATE EORTC 90101

Cross-tumoral Phase 2 Clinical Trial Exploring Crizotinib (PF-02341066) in Patients With Advanced Tumors Induced by Causal Alterations of ALK and/or MET

Laatste aanpassing: 12 oktober 2020